Literature DB >> 28987797

Investigating the site selective binding of busulfan to human serum albumin: Biophysical and molecular docking approaches.

Mohammad Siddiqi1, Saima Nusrat1, Parvez Alam1, Sadia Malik1, Sumit Kumar Chaturvedi1, Mohammad Rehan Ajmal1, Ali Saber Abdelhameed2, Rizwan Hasan Khan3.   

Abstract

We have studied the binding of busulfan (BN) to human serum albumin (HSA) at physiological pH 7.4 by using fluorescence, UV-vis and circular dichroism (CD) spectroscopic tools, as well as dynamic light scattering (DLS) measurements and molecular simulation approaches. HSA fluorescence quenching experiments showed that BN reduces the HSA native fluorescence intensity through the static mechanism. In addition, a single binding site on the HSA is occupied by BN with a binding constant at 298K of 1.84×103M-1. The enthalpy change (ΔH) and entropy change (ΔS) of BN-HSA interaction were calculated as -1.40kcalmol-1 and +10.14calmol-1K-1 respectively, which suggest the possible interaction mode as hydrophobic and hydrogen bonding. Moreover, the secondary structure alteration of HSA following its complexation with BN was studied and showed that α-helical content of HSA gets increased on interacting with BN. Ligand binding site to HSA was further investigated by site-specific markers in fluorescence measurements as well molecular modeling approach which indicated that BN bind to the nearby sudlow site II of HSA through hydrophobic as well as hydrogen bonding interaction. The present study will be helpful for understanding the binding mechanism of BN to human serum albumin.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Binding; Fluorescence quenching; Molecular docking; Serum albumin

Mesh:

Substances:

Year:  2017        PMID: 28987797     DOI: 10.1016/j.ijbiomac.2017.10.006

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  7 in total

1.  Inactivation of Alpha-2-Macroglobulin by Photo-Illuminated Gallic Acid.

Authors:  Tooba Siddiqui; Mohammad Khalid Zia; Syed Saqib Ali; Haseeb Ahsan; Fahim Halim Khan
Journal:  J Fluoresc       Date:  2019-07-20       Impact factor: 2.217

2.  Insights into the interaction of potent antimicrobial chalcone triazole analogs with human serum albumin: spectroscopy and molecular docking approaches.

Authors:  Priyanka Yadav; Jitendra Kumar Yadav; Alka Agarwal; Satish K Awasthi
Journal:  RSC Adv       Date:  2019-10-08       Impact factor: 4.036

3.  Biophysical Insight into the Interaction of Human Lysozyme with Anticancer Drug Anastrozole: A Multitechnique Approach.

Authors:  Fahad M Almutairi; Mohammad Rehan Ajmal; Adel Ibrahim Al Alawy; Rizwan Hasan Khan; Ali Saber Abdelhameed
Journal:  ScientificWorldJournal       Date:  2020-08-25

4.  Interaction of Conazole Pesticides Epoxiconazole and Prothioconazole with Human and Bovine Serum Albumin Studied Using Spectroscopic Methods and Molecular Modeling.

Authors:  Katarína Golianová; Samuel Havadej; Valéria Verebová; Jozef Uličný; Beáta Holečková; Jana Staničová
Journal:  Int J Mol Sci       Date:  2021-02-15       Impact factor: 5.923

5.  A Comprehensive Study on the Biological Activity of Elderberry Extract and Cyanidin 3-O-Glucoside and Their Interactions with Membranes and Human Serum Albumin.

Authors:  Paulina Strugała; Sabrina Loi; Barbara Bażanów; Piotr Kuropka; Alicja Z Kucharska; Aleksandra Włoch; Janina Gabrielska
Journal:  Molecules       Date:  2018-10-08       Impact factor: 4.411

6.  Albumin binding and anticancer effect of magnesium oxide nanoparticles.

Authors:  Elham Behzadi; Rozhin Sarsharzadeh; Mina Nouri; Farnoosh Attar; Keivan Akhtari; Koorosh Shahpasand; Mojtaba Falahati
Journal:  Int J Nanomedicine       Date:  2018-12-27

7.  Molecular Interaction of Amino Acid-Based Gemini Surfactant with Human Serum Albumin: Tensiometric, Spectroscopic, and Molecular Docking Study.

Authors:  Jeenat Aslam; Irfan Hussain Lone; Nagi R E Radwan; Mohd Faizan Siddiqui; Shazia Parveen; Rua B Alnoman; Ruby Aslam
Journal:  ACS Omega       Date:  2019-12-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.